Aminophylline reduces the risk of death in people with septic shock.

Published Date: 10 Mar 2023

A recent study by Ruifang Zhang and colleagues showed that aminophylline reduced the risk of death and prolonged survival in patients with sepsis. more...

Read Full News

Latest News

Maternal BMI and Birth Length Tied to Dermatitis Risk

A higher maternal prepregnancy BMI and greater birth length are associated with an elevated risk for atopic dermatitis in offspring by 3 years of age, new research shows.

Diabetologists On the Rise as Disease Overwhelms Practices

The launch of the American College of Diabetology has helped dozens of physicians become board-certified, with more on the way.

CMA Funds Program to HELP International Physicians Practice

A new commitment will support a program that familiarizes internationally trained physicians with medical English and the Canadian healthcare system.

Doctors Fired After Unionizing Win Settlement From Employer

Peak Vista Community Health Centers will pay $1.2 million to four physicians and a nurse practitioner after a decision by the National Labor Relations Board.

Medical Bulletin 09/December 2023.

The most important medical news of the day is as follows: early age at first menstrual cycle associated with increased risk of diabetes in middle age.

Todays Updates

Real-World EV Plus Pembro Success Seen in Urothelial Cancer

A retrospective study evaluates outcomes associated with first-line enfortumab vedotin plus pembrolizumab vs gemcitabine plus cisplatin in patients with metastatic urothelial carcinoma.

Germline Variants Predict Lobular Breast Cancer Recurrence

For women with invasive lobular carcinoma, pathogenic variants in breast cancer risk genes predict high odds of early recurrence.

MRI Enhancement Predicts Breast Cancer in BRCA Carriers

Higher background parenchymal enhancement on breast MRI may signal greater risk among women who carry BRCA mutations.

Polatuzumab Vedotin Boosts Survival in Relapsed DLBCL

Patients with relapsed or refractory diffuse large B-cell lymphoma, who were ineligible for autologous stem cell transplant, were randomly assigned to receive Pola-R-GemOx or R-GemOx.

Todays Updates

Real-World EV Plus Pembro Success Seen in Urothelial Cancer

A retrospective study evaluates outcomes associated with first-line enfortumab vedotin plus pembrolizumab vs gemcitabine plus cisplatin in patients with metastatic urothelial carcinoma.

Germline Variants Predict Lobular Breast Cancer Recurrence

For women with invasive lobular carcinoma, pathogenic variants in breast cancer risk genes predict high odds of early recurrence.

MRI Enhancement Predicts Breast Cancer in BRCA Carriers

Higher background parenchymal enhancement on breast MRI may signal greater risk among women who carry BRCA mutations.

Polatuzumab Vedotin Boosts Survival in Relapsed DLBCL

Patients with relapsed or refractory diffuse large B-cell lymphoma, who were ineligible for autologous stem cell transplant, were randomly assigned to receive Pola-R-GemOx or R-GemOx.

Latest News

A higher maternal prepregnancy BMI and greater birth length are associated with an elevated risk for atopic dermatitis in offspring by 3 years of age, new research shows.

The launch of the American College of Diabetology has helped dozens of physicians become board-certified, with more on the way.

A new commitment will support a program that familiarizes internationally trained physicians with medical English and the Canadian healthcare system.

Peak Vista Community Health Centers will pay $1.2 million to four physicians and a nurse practitioner after a decision by the National Labor Relations Board.

The most important medical news of the day is as follows: early age at first menstrual cycle associated with increased risk of diabetes in middle age.

News All Time

Check the facts: Posts on social media asserting that biology is not necessary for NEET UG are false.

posts on social media asserting that biology coursework is no longer necessary for those aspiring to become doctors in order to take the National Eligibility-cum-Entrance Test.

Kerala High Court orders Time-Bound Immediate Investigation into Unnecessary Embarrassment of Doctors from Delayed Medical Negligence Probe.

New Delhi: The Kerala High Court on Monday highlighted the possibility that physicians who are innocent could be subjected to needless humiliation should the investigation delay.

Eugene A. Woods joins the board of directors at JnJ.

Johnson and Johnson has announced in New Brunswick that Eugene A. The new CEO of Advocate Health is Woods, MBA, MHA.

Only 30% of doctors' families who passed away from COVID-19 received compensation up until 2023:RTI.

In response to a Right to Information query asking about the total Covid martyrs compensated under the Pradhan Mantri Garib Kalyan Package (PMGKP),.

Medical students from Manipur who have been displaced are able to pursue their education via online or hybrid modes thanks to NMC.

The Undergraduate Medical Education Board (UGMEB) of the National Medical Commission (NMC) has permitted displaced parties, providing a remarkable reprieve.

Incorporate the Ankle Brachial Index examination to rule out peripheral artery disease: A CDSCO Panel Notifies Lupin Regarding Denosumab PK/PD Research.

New Delhi: Under the Central Drug Standard Control, the Subject Expert Committee (SEC) has approved the drug major Lupin.

Delhi High Court: MCI sanctions cannot be used as a yardstick for determining a doctor's shortcomings, flaws, or insufficiency.

New Delhi: The Delhi High Court recently declared that the punishment awarded by the MCI, which is now the National Medical Commission (NMC), could not be an.

As per JAMA, Prone Positioning Has No Effect on the Length of ECMO Weaning in Covid Patients with Severe ARDS.

According to Matthieu Schmidt and colleagues, a randomized clinical trial examined the effects of prone positioning on patients suffering from severe acute respiratory distress.

Rituximab and glucocorticoids in Wegener's Granulomatosis: A PMS Study Report approved by the CDSCO Panel.

New Delhi: The Central Drug Standard Control Organization (CDSCO)'s Subject Expert Committee (SEC) has authorized a post-marketing.

The manufacture and marketing of Azelnidipine and Metoprolol FDC tablets has been approved by the CDSCO Panel for Akum Pharmaceutical.

New Delhi: The Subject Expert Committee (SEC) operating under the Central Drug Standard has given the go-ahead to the pharmaceutical giant Akum Pharmaceuticals.

Health Bulletin / November 30, 2023.

Following a spike in respiratory cases, Uttarakhand and Karnataka are on alert due to a pneumonia outbreak in China. These are the top health stories of the day.

The MP government issues a directive to Yatharth Hospital to assume control of the Ramraja Hospital grounds.

MP: As a result of an order from the Commissionerate of Sagar Sambhag, Madhya, Yatharth Hospital experienced significant trouble yesterday.

Check Your Information: Media reports asserting that biology is not necessary for NEET UG are false.

New Delhi: Posts on social media assert that biology coursework is no longer necessary for applicants to the National Exam to pursue careers in medicine.

The deadline to submit course preferences, willingness to work, and fee for the special straw vacancy round for PG medical seats in Puducherry is today.

The Centralized Admission Committee (CENTAC) in Puducherry has released a notification concerning the special stray vacancy round for three open NEET PG seats.

A radiologist found guilty of violating the PC PNDT Act received a two-year rigorous prison sentence.

A session court in Jabalpur has found a DMRD doctor guilty of a heinous violation of the Pre-Conception and Pre-Natal Diagnostic Techniques (PCPNDT) Act.

Provide Justification for Research on Tocilizumab in Patients with Giant Cell Arteritis: Cipla Hears from the CDSCO Panel.

Examining the procedure that the pharmaceutical company Cipla submitted for the approval of post-marketing active surveillance of tocilizumab in patients in New Delhi.

Recommended News For You

Hematocrit Stabilized in Polycythemia Vera Under Novel Hepcidin Mimetic Treatment.

Potential targets for treating the most common type of liver cancer in children have been identified by a collaborative study.

Chemotherapy can be a challenging treatment?here's how to deal with some of the side-effects

More People Than Previously Believed Have Schizophrenia.

Good News for CAR-T Therapy; Liquid Biopsy Progress; Anti-Psychotic for Brain Cancer

The FDA approves Enhertu for HER2-positive cancers, regardless of tumor type.

A consensus statement from researchers on the proper use of Lu-177 PSMA-617 radionuclide therapy and patient selection is published.

Recommended Articles For You

Exploring the Latest Treatments for Essential Thrombocythemia 

Comprehensive Developments in Hematology in Daily Practice 

The Statistical Imperative: Navigating Trends, Precision, and Innovation in Gynecologic Oncology 2025 

Advanced Approaches in Oncology and Patient Outcomes 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

PSA Testing Is Not Enough for Another Candidate for Prostate Cancer Screening.

2.

As compared to proton therapy, proton therapy is very effective in treating esophageal cancer.

3.

Alkem introduces cetuximab under the trade name Cetuxa in India.

4.

Five new papers highlight cancer inequities, challenges and opportunities in South Asia

5.

Personalized Breast Cancer Treatment; Insights Into HPV in Men; Exercise and Cancer

1.

HPV Infection Review: Epidemiology, Risks, and Therapeutic Advances for Clinicians

2.

Angina Haemorrhagica Bullosa: What You Need to Know

3.

Exploring the Causes and Treatments of Cysts: A Comprehensive Guide

4.

Overcoming Immunotherapy Resistance: Novel Checkpoints, Biomarkers, and Emerging Therapeutic Strategies

5.

The Unseen Danger of Anal Cancer: How to Protect Yourself

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

International Cancer Conference

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V

2.

Dacomitinib Case Presentation: Baseline Treatment and Current Status

3.

Expert Group meeting with the management of EGFR mutation positive NSCLC - Part IV

4.

Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part III

5.

First-Line Maintenance Therapy for Metastatic Urothelial Carcinoma: Bridging Clinical Practice and Trials

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot